Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Tomasz Beer, MD, FACP

Can multi-cancer early detection (MCED) tests potentially lead to a reduction in the number of people who die from the disease by improving screening rates and extending screening for cancers without standard screening today? So what do we need to know about these tests? To discuss this more in-depth, Dr. Charles Turck is joined by Dr. Tomasz Beer, Chief Medical Officer for Multi-Cancer Early Detection at Exact Sciences Corporation and Adjunct Professor of Medicine at the OHSU Knight Cancer Institute.

© 2022 Exact Sciences Corporation. All rights reserved.
US.CAG.00020.HCP 12/22